Nuclear accumulation of WT1 may enhance its binding to the CDK14 promoter, activating the transcriptional activity of CDK14 and thereby promoting the malignant phenotype of NSCLC cells. The gene discussed is CDK14; the disease is non-small cell lung carcinoma.